Study design
EMERGENCY, UTI
A total of 349 patients were enrolled in two open-label, monocentric, non-interventional clinical trials in collaboration with the Department of Emergency Medicine at Azienda Ospedaliera Sant’Andrea, Rome and the outpatient clinic at Istituto Dermopatico dell’Immacolata, Rome; 101 and 248 patients were enrolled in the two facilities, respectively, between November 2015 and December 2017. Prior to study participation, each patient was asked to read carefully through the patient information sheet and signed the informed consent. Approval of the study was obtained on 14.01.2013 from the Ethical Committee of Azienda Ospedaliera Sant’Andrea, and on 25.05.2017 from the Ethical Committee of Istituto Dermopatico dell’Immacolata, constituted according to DM 12.05.2006 following Good Clinical Practice. Authorization was given based on the declaration that the patients were duly informed and consenting. Only patients subscribing the informed consent were enrolled. The clinical trial did not imply any change in the normal diagnostic and therapeutic procedures.Among patients enrolled in the two studies, AST was carried out on a total of 97 patients diagnosed with UTI upon urine culture, after admission in the health care facilities.